BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martinez Velazquez LA, Ballios BG. The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease. Int J Mol Sci 2021;22:11542. [PMID: 34768969 DOI: 10.3390/ijms222111542] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Martínez-gil N, Maneu V, Kutsyr O, Fernández-sánchez L, Sánchez-sáez X, Sánchez-castillo C, Campello L, Lax P, Pinilla I, Cuenca N. Cellular and molecular alterations in neurons and glial cells in inherited retinal degeneration. Front Neuroanat 2022;16:984052. [DOI: 10.3389/fnana.2022.984052] [Reference Citation Analysis]
2 Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Sampani K, Steliou K, Tamvakopoulos C, Vavvas DG, Zamboni RJ, Chen X. Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury. Biochem Pharmacol 2022;203:115168. [PMID: 35835206 DOI: 10.1016/j.bcp.2022.115168] [Reference Citation Analysis]
3 Navinés-ferrer A, Ruiz-nogales S, Navarro R, Pomares E. Impaired Bestrophin Channel Activity in an iPSC-RPE Model of Best Vitelliform Macular Dystrophy (BVMD) from an Early Onset Patient Carrying the P77S Dominant Mutation. IJMS 2022;23:7432. [DOI: 10.3390/ijms23137432] [Reference Citation Analysis]